- Home
- MYGN vs LMND Comparison
MYGN vs LMND Comparison
Compare MYGN & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- LMND
- Stock Information
- Founded
- MYGN 1991
- LMND 2015
- Country
- MYGN United States
- LMND United States
- Employees
- MYGN N/A
- LMND N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LMND Property-Casualty Insurers
- Sector
- MYGN Health Care
- LMND Finance
- Exchange
- MYGN Nasdaq
- LMND Nasdaq
- Market Cap
- MYGN 2.0B
- LMND 2.0B
- IPO Year
- MYGN 1995
- LMND 2020
- Fundamental
- Price
- MYGN $15.25
- LMND $33.30
- Analyst Decision
- MYGN Buy
- LMND Hold
- Analyst Count
- MYGN 12
- LMND 6
- Target Price
- MYGN $27.64
- LMND $24.60
- AVG Volume (30 Days)
- MYGN 990.7K
- LMND 2.4M
- Earning Date
- MYGN 11-07-2024
- LMND 10-30-2024
- Dividend Yield
- MYGN N/A
- LMND N/A
- EPS Growth
- MYGN N/A
- LMND N/A
- EPS
- MYGN N/A
- LMND N/A
- Revenue
- MYGN $823,600,000.00
- LMND $492,500,000.00
- Revenue This Year
- MYGN $13.85
- LMND N/A
- Revenue Next Year
- MYGN $7.73
- LMND $26.74
- P/E Ratio
- MYGN N/A
- LMND N/A
- Revenue Growth
- MYGN 12.15
- LMND 22.09
- 52 Week Low
- MYGN $15.18
- LMND $14.03
- 52 Week High
- MYGN $29.30
- LMND $35.17
- Technical
- Relative Strength Index (RSI)
- MYGN 16.18
- LMND 75.00
- Support Level
- MYGN $16.86
- LMND $31.41
- Resistance Level
- MYGN $19.60
- LMND $34.95
- Average True Range (ATR)
- MYGN 1.17
- LMND 2.44
- MACD
- MYGN -0.25
- LMND 0.89
- Stochastic Oscillator
- MYGN 0.90
- LMND 89.17
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
About LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.